about
Genome plasticity of BCG and impact on vaccine efficacyA point mutation in cycA partially contributes to the D-cycloserine resistance trait of Mycobacterium bovis BCG vaccine strainsCharacterization of the transcriptional regulator Rv3124 of Mycobacterium tuberculosis identifies it as a positive regulator of molybdopterin biosynthesis and defines the functional consequences of a non-synonymous SNP in the Mycobacterium bovis BCGTuberculosis vaccine strain Mycobacterium bovis BCG Russia is a natural recA mutantNovel genetic polymorphisms that further delineate the phylogeny of the Mycobacterium tuberculosis complex.Novel genome polymorphisms in BCG vaccine strains and impact on efficacy.Reducing the activity and secretion of microbial antioxidants enhances the immunogenicity of BCG.Strain-specific differences in the genetic control of two closely related mycobacteriaThe Impact of Genome Region of Difference 4 (RD4) on Mycobacterial Virulence and BCG Efficacy.Revisiting the evolution of Mycobacterium bovisPerspectives on clinical and preclinical testing of new tuberculosis vaccines.Novel multiplex PCR using dual-priming oligonucleotides for detection and discrimination of the Mycobacterium tuberculosis complex and M. bovis BCG.Region of difference 2 contributes to virulence of Mycobacterium tuberculosis.Mycobacterium tuberculosis H37Rv: Delta RD1 is more virulent than M. bovis bacille Calmette-Guérin in long-term murine infection.Joint effects of host genetic background and mycobacterial pathogen on susceptibility to infection.Genome sequence of Mycobacterium bovis BCG Moreau, the Brazilian vaccine strain against tuberculosis.Genomic analysis of a Mycobacterium bovis bacillus [corrected] Calmette-Guérin strain isolated from an adult patient with pulmonary tuberculosis..BCG sub-strains induce variable protection against virulent pulmonary Mycobacterium tuberculosis infection, with the capacity to drive Th2 immunityPopulation genomics of Mycobacterium tuberculosis in the InuitBCG vaccine in Korea.Genomic analysis distinguishes Mycobacterium africanum.Extensive genomic polymorphism within Mycobacterium avium.The BCG replacement vaccine VPM1002: from drawing board to clinical trial.Immune response induced by three Mycobacterium bovis BCG substrains with diverse regions of deletion in a C57BL/6 mouse model.Strain-dependent variation in Mycobacterium bovis BCG-induced human T-cell activation and gamma interferon production in vitro.Evolution of bacterial virulence.Complete Genome Sequence of Mycobacterium bovis Strain BCG-1 (Russia).A comprehensive survey of single nucleotide polymorphisms (SNPs) across Mycobacterium bovis strains and M. bovis BCG vaccine strains refines the genealogy and defines a minimal set of SNPs that separate virulent M. bovis strains and M. bovis BCG strThe ESAT6 protein of Mycobacterium tuberculosis induces apoptosis of macrophages by activating caspase expression.Genomic interrogation of the dassie bacillus reveals it as a unique RD1 mutant within the Mycobacterium tuberculosis complex.Impact of methoxymycolic acid production by Mycobacterium bovis BCG vaccines.Identification of mycobacterial sigma factor binding sites by chromatin immunoprecipitation assaysRecurrent tuberculosis: relapse, reinfection, and HIV.Molecular detection of Mycobacterium bovis and Mycobacterium bovis BCG (Pasteur) in soil.Defining pathogenic bacterial species in the genomic era.Modulation of humoral immune response to oral BCG vaccination by Mycobacterium bovis BCG Moreau Rio de Janeiro (RDJ) in healthy adults.Tuberculosis testing in deer - Scientific Opinion of the Panel on Animal Health and WelfareEvolution and Strain Variation in BCG.
P2860
Q24674276-646B35B8-7847-4817-83BA-2C0BF0470636Q28482347-AD15B0ED-7AAC-45EA-88AA-782000452798Q28487633-0918FCE2-5C6A-4EE7-927C-9B81DC2C9D6AQ30845265-084D644D-C386-4623-8C93-01964A152B86Q31043162-6954356F-CD8F-4CA3-9C44-E6CFEE959B2CQ33369563-3BC9CF53-1F2B-4C26-B3AB-86FBEC726ED7Q33444699-1F6BE264-D0D4-4F68-B758-C21D321CF094Q33741967-49B73687-AFAC-4D28-9F81-BC74B4FF967CQ33774577-53492833-5898-4995-A737-41F3B5613CFAQ34048389-F1BEE6B1-342E-452C-9777-EE20F3D16A02Q34189865-594BD231-5641-4CC4-B10C-FFF96DFB02EAQ34433092-90A3517B-28E9-496A-9046-F7A39D8712A4Q34484770-4931B277-0243-4C19-B5F2-9F3FCB649704Q34595275-07A753BC-B0DF-424D-939E-DEECFB41B9C6Q35075851-F45DBEEB-E9D1-40B3-88D8-2240BBB101F7Q35274553-0488585A-553B-40FE-951F-5363BEBC1B54Q35390426-F7E780DE-16CB-4C74-A257-283FC6280A39Q35575809-D0B549B3-43FB-4D6B-BF69-9A0C9A1B4826Q36268497-1D6C5FFB-A138-43C7-BDB0-48C517C87C0BQ37011018-982215EF-9B2E-4EA5-BBC8-FA41538BB2ABQ37156961-2A4AF3E0-DBFB-4132-B8C8-8A97B346C389Q37494465-F87D4AB6-9319-466E-821F-E03A6A4AD8E5Q38202181-2E8AEC87-AE8E-4ECB-801A-E08F0239A91DQ38606984-D996189D-2183-4370-B24A-7B929FEE751AQ38862796-4FA76B00-338E-4045-920B-C63FC79C9FCDQ39322429-F6110CD4-B4AF-4E2A-9F09-78198296407CQ39756272-687B838E-35AB-42A8-A9CE-A8F14943B1CCQ39994755-06D7F7E4-1914-4343-BA58-67BFD63F3556Q40171434-C402D251-7AC6-4EC1-A1FA-1FEC7BF4599FQ40377422-E4F58463-D02C-46F7-A693-3CC5BA42F786Q40563998-24FB817A-F0FA-4261-A07A-59499D0DEC98Q42060168-BAEE3C4B-7D6A-4BC4-A1AE-B26D8B9DBE9FQ42076385-61DBFA4F-6CEB-4589-9BED-A122BF3E9D7EQ42122709-F5585302-98B9-49BF-9EA4-586E48E2ADDFQ42732033-965AB5C3-734A-4027-85D2-4910F690964AQ43237777-22BA5917-3BEE-4C97-8483-A8AA9AB97338Q47145275-D30E2CF2-A2AB-489B-8003-2AB8E2721C0CQ47223264-5AC7670F-6EB0-4CDF-81E5-40F612D89577
P2860
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
The in vitro evolution of BCG vaccines.
@en
The in vitro evolution of BCG vaccines.
@nl
type
label
The in vitro evolution of BCG vaccines.
@en
The in vitro evolution of BCG vaccines.
@nl
prefLabel
The in vitro evolution of BCG vaccines.
@en
The in vitro evolution of BCG vaccines.
@nl
P2093
P1433
P1476
The in vitro evolution of BCG vaccines.
@en
P2093
Anthony G Tsolaki
Marcel A Behr
Peter M Small
P304
P356
10.1016/S0264-410X(03)00484-5
P407
P577
2003-10-01T00:00:00Z